Literature DB >> 6568181

Increased translational fidelity caused by the antibiotic kasugamycin and ribosomal ambiguity in mutants harbouring the ksgA gene.

C P van Buul, W Visser, P H van Knippenberg.   

Abstract

The aminoglycoside kasugamycin, which has previously been shown to inhibit initiation of protein biosynthesis in vitro, also affects translational accuracy in vitro. This is deduced from the observation that the drug decreases the incorporation of histidine relative to alanine into the coat protein of phage MS2, the gene of which is devoid of histidine codons. The read-through of the MS2 coat cistron, due to frameshifts in vitro, is also suppressed by the antibiotic. In contrast, streptomycin enhances histidine incorporation and read-through in this system. The effects of kasugamycin take place at concentrations that do not inhibit coat protein biosynthesis. Kasugamycin-resistant mutants (ksgA) lacking dimethylation of two adjacent adenosines in 16 S ribosomal RNA, show an increased leakiness of nonsense and frameshift mutants (in the absence of antibiotic). They are therefore phenotypically similar to previously described ribosomal ambiguity mutants (ram).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6568181     DOI: 10.1016/0014-5793(84)80994-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

1.  Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic.

Authors:  Letizia Brandi; Attilio Fabbretti; Anna La Teana; Monica Abbondi; Daniele Losi; Stefano Donadio; Claudio O Gualerzi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

2.  Multiple defects in translation associated with altered ribosomal protein L4.

Authors:  Michael O'Connor; Steven T Gregory; Albert E Dahlberg
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

Review 3.  Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications.

Authors:  Christine S Chow; Tek N Lamichhane; Santosh K Mahto
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

4.  Role of 16S ribosomal RNA methylations in translation initiation in Escherichia coli.

Authors:  Gautam Das; Dinesh Kumar Thotala; Suman Kapoor; Sheelarani Karunanithi; Suman S Thakur; N Sadananda Singh; Umesh Varshney
Journal:  EMBO J       Date:  2008-02-21       Impact factor: 11.598

5.  Identification and role of functionally important motifs in the 970 loop of Escherichia coli 16S ribosomal RNA.

Authors:  Ashesh A Saraiya; Tek N Lamichhane; Christine S Chow; John SantaLucia; Philip R Cunningham
Journal:  J Mol Biol       Date:  2007-12-07       Impact factor: 5.469

6.  Dimethyl adenosine transferase (KsgA) deficiency in Salmonella enterica Serovar Enteritidis confers susceptibility to high osmolarity and virulence attenuation in chickens.

Authors:  Kim Lam Chiok; Tarek Addwebi; Jean Guard; Devendra H Shah
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

7.  Appropriate maturation and folding of 16S rRNA during 30S subunit biogenesis are critical for translational fidelity.

Authors:  Biswajoy Roy-Chaudhuri; Narayanaswamy Kirthi; Gloria M Culver
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

8.  Decoding fidelity at the ribosomal A and P sites: influence of mutations in three different regions of the decoding domain in 16S rRNA.

Authors:  M O'Connor; C L Thomas; R A Zimmermann; A E Dahlberg
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

9.  Mechanistic insight into the ribosome biogenesis functions of the ancient protein KsgA.

Authors:  Keith Connolly; Jason P Rife; Gloria Culver
Journal:  Mol Microbiol       Date:  2008-12       Impact factor: 3.501

10.  In vitro methylation of Escherichia coli 16S ribosomal RNA and 30S ribosomes.

Authors:  D Nègre; C Weitzmann; J Ofengand
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.